These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2490830)

  • 1. Potential impact of exclusion criteria on results of hypertension trials.
    Remington RD
    Hypertension; 1989 May; 13(5 Suppl):I66-8. PubMed ID: 2490830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled clinical trials of drug treatment for hypertension. A review.
    Cutler JA; MacMahon SW; Furberg CD
    Hypertension; 1989 May; 13(5 Suppl):I36-44. PubMed ID: 2490827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the long-term controlled trials of usefulness of therapy for systemic hypertension.
    Gifford RW
    Am J Cardiol; 1989 Jan; 63(4):8B-16B. PubMed ID: 2563189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group.
    Prev Med; 1976 Jun; 5(2):207-15. PubMed ID: 935073
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the impact of sample size calculation and power in clinical research].
    Held U
    Praxis (Bern 1994); 2014 Oct; 103(20):1197-201. PubMed ID: 25270749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension. Prepared for the Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension.
    Ann N Y Acad Sci; 1978 Mar; 304():267-92. PubMed ID: 360921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic use of lowering blood pressure, especially in mild hypertension. Results of a hypertension detection and treatment program].
    Comberg HU; Heyden S
    Z Gesamte Inn Med; 1986 Jun; 41(12):333-40. PubMed ID: 3765731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the rising placebo response impact antihypertensive clinical trial outcomes? An analysis of data from the Food and Drug Administration 1990-2016.
    Khan A; Fahl Mar K; Schilling J; Brown WA
    PLoS One; 2018; 13(2):e0193043. PubMed ID: 29489874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in various intervention trials in elderly hypertensive patients: a review.
    Staessen J; Fagard R; Van Hoof R; Amery A
    Eur Heart J; 1988 Feb; 9(2):215-22. PubMed ID: 3280319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing face of clinical trials.
    Kitler ME
    J Hypertens Suppl; 1988 Nov; 6(1):S73-80. PubMed ID: 3063796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of mortality reduction after the end of randomized therapy in clinical trials of blood pressure-lowering medications.
    Kostis WJ; Thijs L; Richart T; Kostis JB; Staessen JA
    Hypertension; 2010 Dec; 56(6):1060-8. PubMed ID: 20975031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antihypertensive agents on quality of life in the elderly.
    Fogari R; Zoppi A
    Drugs Aging; 2004; 21(6):377-93. PubMed ID: 15084140
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.